These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5794854)

  • 21. A comparative study of butaperazine, chlorpromazine and placebo in chronic schizophrenics.
    Keskiner A; Itil TM; Todt N
    Psychosomatics; 1970; 11(2):120-6. PubMed ID: 4394278
    [No Abstract]   [Full Text] [Related]  

  • 22. [Psychotherapy of a schizophrenic patient in a large psychiatric hospital--therapeutic option or naive idealism].
    Branik E
    Psychother Psychosom Med Psychol; 1994 Dec; 44(12):426-31. PubMed ID: 7846270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance tests in a study of phenothiazines in schizophrenia: caveats and conclusions.
    Schooler NR; Goldberg SC
    Psychopharmacologia; 1972; 24(1):81-98. PubMed ID: 5062969
    [No Abstract]   [Full Text] [Related]  

  • 24. Carphenazine in the treatment of schizophrenic psychoses. Controlled clinical trial.
    Vinar O; Formánková M; Taussigová D; Růzicka S
    Act Nerv Super (Praha); 1967 Nov; 9(4):353-5. PubMed ID: 4889058
    [No Abstract]   [Full Text] [Related]  

  • 25. Postrelease adjustment of day and full-time psychiatric patients.
    Michaux MH; Chelst MR; Foster SA; Pruim RJ; Dasinger EM
    Arch Gen Psychiatry; 1973 Nov; 29(5):647-51. PubMed ID: 4149326
    [No Abstract]   [Full Text] [Related]  

  • 26. Reduction in hospitalization of schizophrenics.
    Claghorn JL; Kinross-Wright J
    Am J Psychiatry; 1971 Sep; 128(3):344-7. PubMed ID: 4328320
    [No Abstract]   [Full Text] [Related]  

  • 27. Significant social variables in favorable community adjustment of schizophrenics: a 5-year follow-up.
    Klein HE; Person TM; Itil TM; Marchbank G
    Am J Public Health; 1974 Aug; 64(8):813-4. PubMed ID: 4152008
    [No Abstract]   [Full Text] [Related]  

  • 28. A double-blind comparison of the therapeutic efficacy of mesoridazine versus chlorpromazine.
    Freeman H; Oktem MR; Oktem N
    Curr Ther Res Clin Exp; 1969 May; 11(5):263-70. PubMed ID: 4977397
    [No Abstract]   [Full Text] [Related]  

  • 29. Predictor patterns in the management of therapy-resistant schizophrenia.
    Holden JM; Hsu W; Itil TM; Keskiner A
    Dis Nerv Syst; 1971 Apr; 32(4):260-8. PubMed ID: 4397410
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in ward behaviour of severely disabled schizophrenic patients.
    Ekdawi MY
    Br J Psychiatry; 1966 Mar; 112(484):265-7. PubMed ID: 5939888
    [No Abstract]   [Full Text] [Related]  

  • 31. The prevention of hospitalization in schizophrenia: five years after an experimental program.
    Davis AE; Dinitz S; Pasamanick B
    Am J Orthopsychiatry; 1972 Apr; 42(3):375-88. PubMed ID: 4335894
    [No Abstract]   [Full Text] [Related]  

  • 32. [Intensity of psychotic symptoms and selected demographic data as predictors of effectiveness of psychotherapy of schizophrenic patients in a day-hospital treatment].
    Kamiński R; Lisiecka A
    Psychiatr Pol; 2002; 36(2):211-23. PubMed ID: 12043040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of changes in severity of the schizophrenic syndrome with discontinuation and administration of phenothiazines in chronic schizophrenic patients: language as a predictor and measure of change in schizophrenia.
    Gottschalk LA; Gleser GC; Cleghorn JM; Stone WN; Winget CN
    Compr Psychiatry; 1970 Mar; 11(2):123-40. PubMed ID: 5436410
    [No Abstract]   [Full Text] [Related]  

  • 34. A three-year posthospital follow-up of adolescent and adult schizophrenics.
    Pollack M; Levenstein S; Klein DF
    Am J Orthopsychiatry; 1968 Jan; 38(1):95-109. PubMed ID: 5637338
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experiences with intended dynamic group psychotherapy in the complex therapy of schizophrenic patients].
    Ehle G
    Psychiatr Neurol Med Psychol (Leipz); 1987 Feb; 39(2):89-97. PubMed ID: 3588762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High dose trifluoperazine therapy in chronic schizophrenia.
    Prien RF; Levine J; Cole JO
    Am J Psychiatry; 1969 Sep; 126(3):305-13. PubMed ID: 4895559
    [No Abstract]   [Full Text] [Related]  

  • 37. Short-term acute psychiatric care: a follow-up study.
    Penick SB; Byonpane N; Carrier RN
    Am J Psychiatry; 1971 Jun; 127(12):1626-30. PubMed ID: 4327724
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of Tybamate in chronic schizophrenia. (Minor tranquilizers as adjunct therapy in psychosis).
    Serafetinides EA; Clark ML
    Dis Nerv Syst; 1971 Aug; 32(8):567-71. PubMed ID: 5094163
    [No Abstract]   [Full Text] [Related]  

  • 39. [The dynamics of outcome predictors in the early phase of schizophrenic psychoses--an empirical study].
    Hubschmid T; Perrin N; Ciompi L
    Psychiatr Prax; 1991 Nov; 18(6):196-201. PubMed ID: 1771200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short or long hospitalization for psychiatric disorders?
    Glick ID; Hargreaves WA; Drues J; Showstack JA
    Psychopharmacol Bull; 1975 Oct; 11(4):35-7. PubMed ID: 714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.